Mitral Valvuloplasty Score

– share this tool –

Clinical Use

Predict procedural outcome in patients  undergoing mitral valvuloplasty for mitral stenosis

More Info

Mitral Valvuloplasty Scoring is based on the following variables:
ScoreFindings
Leaflet Mobility
1Highly mobile
2Reduced mobility
3Basal leaflet motion only
4Minimal motion
Valve thickening
1Near normal (4-5 mm)
2Thickened tips
3Entire leaflet thickened (5-8 mm)
4Marked leaflet thickening (>8-10 mm)
Calcification
1Single area of brightness
2Scattered areas at leaflet margins
3Brightness extends to mid leaflets
4Extensive leaflet brightness
Subvalvular thickening
1Minimal chordal thickening
2Chordal thickening up to 1/3
3Distal third of chordae thickening
4Extensive thickening to pap muscle

 

Formula:

Mitral Valvuloplasty Score Leaflet Mobility Valve Thickening Calcification Subvalvular Thickening

 

The outcome based on mitral valvuloplasty score
Mitral valvuloplasty score
Poor Outcome≥8
Good Outcome<8

Reference

1.Baumgartner H, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009 Jan;22(1):14, 17. Full text

Disclaimer

We are doing our best to prepare the content of this website. However, Cardiology Connections, Corp cannot warranty the expressions and suggestions of the contents, as well as its accuracy. In addition, to the extent permitted by the law, Cardiology Connections, Corp shall not be responsible for any losses and/or damages due to the usage of the information on our website. Furthermore, the links contained on our website may lead to external sites, which are provided for convenience only. Any information or statements that appeared in these sites are not sponsored, endorsed, or otherwise approved by Cardiology Connections, Corp. For these external sites, Cardiology Connections, Corp cannot be held liable for the availability of, or the content located on or through it. Plus, any losses or damages occurred from using these contents or the internet generally.

Developer: Sirikarn Napan, MD, FACC